IMPROVED SURVIVAL OF POOR PROGNOSIS FDG-AVID NEUROENDOCRINE TUMOURS WITH LU-177 OCTREOTATE PEPTIDE RECEPTOR CHEMORADIONUCLIDE THERAPY (PRCRT): O43
- Resource Type
- Academic Journal
- Source
- Internal Medicine Journal. Apr 01, 2015 45 Suppl 1:13-13
- Subject
- Language
- English
- ISSN
- 1444-0903